lostxn
DCC 4Life
- Joined
- Apr 7, 2013
- Messages
- 7,876
No, that's hydroxychloroquine. We have stopped using that for a month or two because it wasn't helping and then studies showed the same and it has the potential to cause harm. The FDA recently revoked it's emergency use authorization for COVID.Is that the drug everyone got pissed at Trump for mentioning?
Also I know historically these viruses tend to become weaker as time goes on. Couldn't that be a big part the lower fatality rate and rate of people needing hospitalization? Essentially the virus is becoming less deadly in general?
June 15, 2020 Update: Based on ongoing analysis and emerging scientific data, FDA has revoked the emergency use authorization (EUA) to use hydroxychloroquine and chloroquine to treat COVID-19 in certain hospitalized patients when a clinical trial is unavailable or participation is not feasible. We made this determination based on recent results from a large, randomized clinical trial in hospitalized patients that found these medicines showed no benefit for decreasing the likelihood of death or speeding recovery. This outcome was consistent with other new data, including those showing the suggested dosing for these medicines are unlikely to kill or inhibit the virus that causes COVID-19. As a result, we determined that the legal criteria for the EUA are no longer met. Please refer to the Revocation of the EUA Letter and FAQs on the Revocation of the EUA for Hydroxychloroquine Sulfate and Chloroquine Phosphate for more information.
Remdesivir is a an anti-viral made by Gilead initially developed for Hep C and then tested on Ebola but was effective for neither. China tested in the sickest of the sick and found little benefit. However, I believe we're seeing if it is used earlier it can be effective. Gilead's own trials showed benefits but people are a bit suspicious. Especially after execs likely leaked the results to drive up the stock price and make each other millions.
But hey whatever works. Fortunately safety for the drug was established already. Unfortunately it's an IV drug so it's not going to be something we can give everyone. Would love to give it out liberally. Might decrease mortality, morbidity and shorten the window of infectivity. Hopefully. More studies needed...